Search Results for: RETA
Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial.
1 year ago
Last Updated: 1 year ago
Reata shares saw a solid gain on Monday after the company reported results from a couple midstage kidney trials.
2 years ago
Last Updated: 1 year ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
3 years ago
Last Updated: 10 months ago
Reata Pharmaceuticals saw its shares make an incredible gain to kick off the week after it reported initial data from its mid-stage trial evaluating bardoxolone in patients with chronic kidney...
3 years ago
Last Updated: 1 year ago
The pending holiday didn’t slow insiders from buying shares, and we continued to see some strong trading during the week.
4 years ago
Last Updated: 1 year ago
The S&P 500 and Dow are pushing new highs as 2016 comes to a close. While the post-election tailwind has been incredibly strong, there are still companies holding back this rally.
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has filed an S-1 form with the U.S. Securities and Exchange Commission for a secondary offering.
4 years ago
Last Updated: 1 year ago
The number of initial public offerings (IPOs) in 2016 grew by five last week, with a food distribution company leading the way.
4 years ago
Last Updated: 1 year ago
While all four of last week’s initial public offerings (IPOs) went out as scheduled, the results were tepid at best. Three of the four price below the mid-point of their expected ranges and the...
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission regarding its initial public offering.
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has amended filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
4 years ago
Last Updated: 1 year ago
Reata Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
5 years ago
Last Updated: 1 year ago
Subscribe to Our Newsletter
Signup for our weekly newsletter to get the latest news, updates & amazing offers delivered directly to your inbox